journal
https://read.qxmd.com/read/38492056/use-of-tryptic-peptide-maldi-mass-spectrometry-imaging-to-identify-the-spatial-proteomic-landscape-of-colorectal-cancer-liver-metastases
#41
JOURNAL ARTICLE
Celine Man Ying Li, Matthew T Briggs, Yea-Rin Lee, Teresa Tin, Clifford Young, John Pierides, Gurjeet Kaur, Paul Drew, Guy J Maddern, Peter Hoffmann, Manuela Klingler-Hoffmann, Kevin Fenix
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. CRC liver metastases (CRLM) are often resistant to conventional treatments, with high rates of recurrence. Therefore, it is crucial to identify biomarkers for CRLM patients that predict cancer progression. This study utilised matrix-assisted laser desorption/ionisation mass spectrometry imaging (MALDI-MSI) in combination with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to spatially map the CRLM tumour proteome...
March 16, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38489142/non-tumor-related-prognostic-factors-for-immunotherapy-chemotherapy-or-immunotherapy-alone-as-first-line-in-advanced-non-small-cell-lung-cancer-nsclc
#42
JOURNAL ARTICLE
Ziwei Guo, Xing Wei, Chuanhao Tang, Jun Liang
Besides programmed death ligand 1 (PD-L1) expression, rapid, cost-effective and validated scores or models are critical for the prognosis and prediction of patients received immune checkpoint inhibitors (ICIs). In this retrospective study, 182 patients with NSCLC receiving ICIs from 2015 to 2022 were divided 1:1 into a training cohort and a validation cohort. We identified a score established by three factors and analyzed the prognostic implications by Kaplan-Meier approach (Log rank test) and time-dependent receiver operating characteristic (ROC) analyses...
March 15, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38441683/whole-exome-sequencing-is-feasible-on-a-fresh-frozen-skin-sample-of-intravascular-large-b-cell-lymphoma
#43
JOURNAL ARTICLE
Filippo Bagnoli, Giuditta Pini, Bachisio Ziccheddu, Arturo Bonometti, Silvia Alberti-Violetti, Luigia Venegoni, Giuseppe Isimbaldi, Matteo Claudio Da Vià, Angela Ferrari, Luca Baldini, Antonino Neri, Francesco Onida, Niccolò Bolli, Emilio Berti
Intravascular large B-cell lymphoma (IVLBCL) is a rare aggressive extranodal non-Hodgkin lymphoma. The predominant, if not exclusive, growth of neoplastic cells within the lumina of small-sized vessels represents the hallmark of the disease. Diagnosis is challenging due to the absence of marked lymphadenopathy, the highly heterogeneous clinical presentation, and the rarity of the condition. Clinical presentation is characterized by variable combinations of nonspecific signs and symptoms (such as fever and weight loss), organ-specific focal manifestations due to altered perfusion, and hemophagocytic syndrome...
March 5, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38430423/runx-transcription-factors-biological-functions-and-implications-in-cancer
#44
REVIEW
Xinyi Chen, Lu Wang, Mu Yang, Weiheng Zhao, Jingyao Tu, Bo Liu, Xianglin Yuan
Runt-related transcription factors (RUNX) are a family of transcription factors that are essential for normal and malignant hematopoietic processes. Their most widely recognized role in malignancy is to promote the occurrence and development of acute myeloid leukemia. However, it is worth noting that during the last decade, studies of RUNX proteins in solid tumors have made considerable progress, suggesting that these proteins are directly involved in different stages of tumor development, including tumor initiation, progression, and invasion...
March 2, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38427120/research-progress-on-the-multi-omics-and-survival-status-of-circulating-tumor-cells
#45
REVIEW
Qingming Xie, Shilei Liu, Sai Zhang, Liqiu Liao, Zhi Xiao, Shouman Wang, Pengfei Zhang
In the dynamic process of metastasis, circulating tumor cells (CTCs) emanate from the primary solid tumor and subsequently acquire the capacity to disengage from the basement membrane, facilitating their infiltration into the vascular system via the interstitial tissue. Given the pivotal role of CTCs in the intricate hematogenous metastasis, they have emerged as an essential resource for a deeper comprehension of cancer metastasis while also serving as a cornerstone for the development of new indicators for early cancer screening and new therapeutic targets...
March 1, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38427086/therapeutic-potential-of-mesenchymal-stem-cell-derived-exosomes-for-regenerative-medicine-applications
#46
REVIEW
Szymon Roszkowski
Mesenchymal stem cell-derived exosomes have emerged as a promising cell-free therapy for tissue engineering. Compared to intact stem cells, exosomes have advantages like low immunogenicity and ability to carry regenerative cargo. This review examined the potential of exosomes to treat defects in skin, bone and cartilage. In preclinical models, exosomes improved wound healing, stimulated bone regeneration, and enabled cartilage repair by transferring proteins, mRNAs and microRNAs. Their effects were elicited by modulating inflammation, angiogenesis, cell proliferation and matrix synthesis...
March 1, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38427082/lymphoma-relapse-1%C3%A2-year-or-later-after-immunochemotherapy-in-dlbcl-patients-clinical-features-and-outcome
#47
JOURNAL ARTICLE
Hongyun Chen, Jinrong Zhao, Danqing Zhao, Wei Wang, Chong Wei, Zi Wang, Daobin Zhou, Wei Zhang
Despite great advances in treatment, 30-40% of patients with DLBCL undergo relapses. Patients with a relapse within 1 year or beyond have a distinct outcome. Few clinical characteristics and survival data in the Chinese population have been published. We aimed to define the incidence and clinical features of DLBCL patients with very early relapse after front-line immunochemotherapy who may benefit greatly from the emerging chimeric antigen receptor T-cell therapy. Data of 564 DLBCL patients were analyzed...
March 1, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38427068/sex-specific-differences-in-icos-t-helper-cell-differentiation-in-systemic-lupus-erythematosus-patients-with-low-disease-activity
#48
JOURNAL ARTICLE
Lisa Wu, Florian Kälble, Hanns-Martin Lorenz, Martin Zeier, Matthias Schaier, Andrea Steinborn
Systemic lupus erythematosus (SLE) is a sex biased chronic autoimmune disease affecting predominantly females during reproductive ages. Changes in the ratio of inducible costimulatory molecule (ICOS)+ regulatory (Treg) and non-regulatory responder (Tresp) CD4+ T cells proved to be crucial for the occurrence of high disease activity. Here, we investigated how the differentiation of ICOS+ CD45RA+ CD31+ recent thymic emigrant (RTE) Tresps into CD45RA- CD31- memory Tresps affects the percentages of ICOS+ Tresps within total CD4+ T cells...
March 1, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38413535/elevated-cd169-expressing-monocyte-macrophage-promotes-systemic-inflammation-and-disease-progression-in-cirrhosis
#49
JOURNAL ARTICLE
Lichen Xu, Chunhong Huang, Xiaoping Zheng, Hainv Gao, Sainan Zhang, Mengfei Zhu, Xiahong Dai, Gang Wang, Jie Wang, Haolu Chen, Haihong Zhu, Zhi Chen
Systemic inflammation is related to disease progression and prognosis in patients with advanced cirrhosis. However, the mechanisms underlying the initiation of inflammation are still not fully understood. The role of CD169+ monocyte/macrophage in cirrhotic systemic inflammation was undetected. Flow cytometry analysis was used to detect the percentage and phenotypes of CD169+ monocytes as well as their proinflammatory function in patient-derived cirrhotic tissue and blood. Transcriptome differences between CD169+ and CD169- monocytes were also compared...
February 28, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38413421/development-and-evaluation-of-nomograms-and-risk-stratification-systems-to-predict-the-overall-survival-and-cancer-specific-survival-of-patients-with-hepatocellular-carcinoma
#50
JOURNAL ARTICLE
Xichun Kang, Xiling Liu, Yaoqi Li, Wenfang Yuan, Yi Xu, Huimin Yan
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and patients with HCC have a poor prognosis and low survival rates. Establishing a prognostic nomogram is important for predicting the survival of patients with HCC, as it helps to improve the patient's prognosis. This study aimed to develop and evaluate nomograms and risk stratification to predict overall survival (OS) and cancer-specific survival (CSS) in HCC patients. Data from 10,302 patients with initially diagnosed HCC were extracted from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2017...
February 28, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38400937/clinical-and-pathological-findings-of-iga-nephropathy-following-sars-cov-2-infection
#51
JOURNAL ARTICLE
Hongfen Li, Zhao Li, Zhanfei Wu, Fanghao Wang, Yue Xing, Youxia Liu, Junya Jia, Tiekun Yan
The features of IgA nephropathy (IgAN) after SARS-CoV-2 infection have not been well characterized. In this study, we compared the clinical and pathological characteristics of patients with IgAN who had experienced SARS-CoV-2 infection to those who had not. We conducted a retrospective study that enrolled 38 patients with biopsy-proven IgAN following SARS-CoV-2 infection with 4 months (post-SARS-CoV-2 infection group) and 1154 patients with IgAN prior to the pandemic (pre-SARS-CoV-2 infection group). Among the SARS-CoV-2 group cases, 61% were females...
February 24, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38400850/causality-between-covid-19-and-multiple-myeloma-a-two-sample-mendelian-randomization-study-and-bayesian-co-localization
#52
JOURNAL ARTICLE
Shuaiyuan Wang, Na Zhao, Ting Luo, Songzi Kou, Miaomiao Sun, Kuisheng Chen
Infection is the leading cause of morbidity and mortality in patients with multiple myeloma (MM). Studying the relationship between different traits of Coronavirus 2019 (COVID-19) and MM is critical for the management and treatment of MM patients with COVID-19. But all the studies on the relationship so far were observational and the results were also contradictory. Using the latest publicly available COVID-19 genome-wide association studies (GWAS) data, we performed a bidirectional Mendelian randomization (MR) analysis of the causality between MM and different traits of COVID-19 (SARS-CoV-2 infection, COVID-19 hospitalization, and severe COVID-19) and use multi-trait analysis of GWAS(MTAG) to identify new associated SNPs in MM...
February 24, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38386169/intestinal-microbiota-regulates-the-gut-thyroid-axis-the-new-dawn-of-improving-hashimoto-thyroiditis
#53
REVIEW
Xiaxin Zhu, Chi Zhang, Shuyan Feng, Ruonan He, Shuo Zhang
Intestinal microbiota plays an indispensable role in the host's innate immune system, which may be related to the occurrence of many autoimmune diseases. Hashimoto thyroiditis (HT) is one of the most common autoimmune diseases, and there is plenty of evidence indicating that HT may be related to genetics and environmental triggers, but the specific mechanism has not been proven clearly. Significantly, the composition and abundance of intestinal microbiota in patients with HT have an obvious difference. This phenomenon led us to think about whether intestinal microbiota can affect the progress of HT through some mechanisms...
February 22, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38386086/immunomodulatory-effects-of-itr35-cell-subpopulation-and-its-research-progress
#54
REVIEW
Chenxi Yang, Lingli Dong, Jixin Zhong
The spotlight in recent years has increasingly focused on inducible regulatory T cells 35 (iTr35), a novel subpopulation of regulatory T cells characterized by phenotypic stability, heightened reactivity, and potent immunosuppressive function through the production of IL-35. Despite being in the exploratory phase, research on iTr35 has garnered significant interest. In this review, we aim to consolidate our understanding of the biological characteristics and immunomodulatory mechanisms of iTr35, offering fresh perspectives that may pave the way for its potential applications in disease diagnosis and treatment...
February 22, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38386053/immune-checkpoint-inhibitors-and-risk-of-immune-mediated-adverse-events-a-cohort-study-comparing-extended-versus-standard-interval-administration
#55
JOURNAL ARTICLE
Amélia Lessard-Roy, Roxanne Marchand, Pierre Lemieux, Mélanie Masse, Alexandre Lacerte, Pierre-Hugues Carmichael, Danielle Laurin
The COVID-19 pandemic precipitated the implementation of extended interval immune checkpoint inhibitors (ICIs) in an effort to limit hospital visits, but few studies have examined their safety. This study aimed to compare in oncology outpatients, immune-mediated adverse events (IMAEs) in terms of total number, incidence, severity, and time to occurrence, based on exposure to standard or extended interval ICIs. A retrospective cohort study was conducted in patients who received at least one dose of an ICI between 2015 and 2021...
February 22, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38367089/treatment-strategies-in-mda5-positive-clinically-amyopathic-dermatomyositis-a-single-center-retrospective-analysis
#56
JOURNAL ARTICLE
Stefanie Hirsch, Gesa Helen Pöhler, Benjamin Seeliger, Antje Prasse, Torsten Witte, Thea Thiele
Melanoma differentiation-associated protein 5 (MDA5) antibody positive amyopathic dermatomyositis (DM) is a rare inflammatory disease. So far, there is no official treatment guideline in MDA5 amyopathic dermatomyositis, but early and aggressive immunosuppressive combination treatment can induce a stable remission. We retrospectively analyzed a cohort of eight patients (male n = 5) that were diagnosed with MDA5-positive amyopathic DM. Patient data comprised demographics, CT-guided diagnosis of pulmonary involvement, pulmonary function testing including forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO) data on baseline and mean long-term follow-up of 51 months (24-92 months) to evaluate treatment strategies...
February 17, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38367035/role-of-zinc-in-health-and-disease
#57
REVIEW
Lucy I Stiles, Kevin Ferrao, Kosha J Mehta
This review provides a concise overview of the cellular and clinical aspects of the role of zinc, an essential micronutrient, in human physiology and discusses zinc-related pathological states. Zinc cannot be stored in significant amounts, so regular dietary intake is essential. ZIP4 and/or ZnT5B transport dietary zinc ions from the duodenum into the enterocyte, ZnT1 transports zinc ions from the enterocyte into the circulation, and ZnT5B (bidirectional zinc transporter) facilitates endogenous zinc secretion into the intestinal lumen...
February 17, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38353722/developing-questions-to-assess-and-measure-patients-perceived-survival-benefit-from-adjuvant-endocrine-therapy-in-breast-cancer-a-mixed-methods-pilot-study
#58
JOURNAL ARTICLE
Bernard Tawfik, Kendal Jacobson, Ursa Brown-Glaberman, Mikaela Kosich, M Lee Van Horn, Jacklyn Nemunaitis, Zoneddy Dayao, V Shane Pankratz, Andrew L Sussman, Dolores D Guest
This mixed method study developed multiple question types to understand and measure women's perceived benefit from adjuvant endocrine therapy. We hypothesis that patients do not understand this benefit and sought to develop the questions needed to test this hypothesis and obtain initial patient estimates. From 8/2022 to 3/2023, qualitative interviews focused on assessing and modifying 9 initial varied question types asking about the overall survival (OS) benefit from adjuvant endocrine therapy. Subsequent focus groups modified and selected the optimal questions...
February 14, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38349460/tet2-mutations-contribute-to-adverse-prognosis-in-acute-myeloid-leukemia-aml-results-from-a-comprehensive-analysis-of-502-aml-cases-and-the-beat-aml-public-database
#59
LETTER
Xin'an Pan, Yingjun Chang, Guorui Ruan, Songhai Zhou, Hao Jiang, Qian Jiang, Xiaojun Huang, Xiao-Su Zhao
Despite the high incidence of tet methylcytosine dioxygenase 2 (TET2) mutations in acute myeloid leukemia (AML), the prognostic implications of these mutations in three AML risk groups based on the 2022 ELN AML risk classification are still unclear. A total of 502 consecutive de novo AML patients who had next-generation sequencing data available between March 2011 and July 2021 at the Peking University Institute of Hematology were enrolled in this study. Univariate and multivariate Cox regression analyses were performed to explore the prognostic impact of TET2 mutations in the above cohort and the Beat AML cohort...
February 13, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38340186/metabolomics-and-lipidomics-signature-in-celiac-disease-a-narrative-review
#60
REVIEW
Mohammad Rostami-Nejad, Nastaran Asri, Sajjad Bakhtiari, Ensieh Khalkhal, Sepehr Maleki, Mostafa Rezaei-Tavirani, Somayeh Jahani-Sherafat, Kamran Rostami
Celiac disease (CD) is a chronic immune-mediated inflammatory disease of the small intestine caused by aberrant immune responses to consumed gluten proteins. CD is diagnosed by a combination of the patients reported symptoms, serologic and endoscopic biopsy evaluation of the small intestine; and adherence to a strict gluten-free diet (GFD) is considered the only available therapeutic approach for this disorder. Novel approaches need to be considered for finding new biomarkers to help this disorder diagnosis and finding a new alternative therapeutic method for this group of patients...
February 10, 2024: Clinical and Experimental Medicine
journal
journal
38106
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.